StonvexLoading…
StonvexStonvexStonvexCore line items from TRAW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.79M | $226.00K | $226.00K | $226.00K |
Operating Income | $-17.88M | $-142.37M | $-20.30M | $-19.63M |
Net Income | $9.17M | $-166.52M | $-18.95M | $-18.96M |
EPS (Diluted) | $0.82 | $-35.21 | $-22.57 | $-0.91 |
Total Assets | $10.62M | $24.96M | $22.68M | $39.37M |
Total Liabilities | $11.25M | $56.59M | $12.01M | $11.06M |
Cash & Equivalents | $3.82M | $21.34M | $20.56M | $38.52M |
Free Cash Flow OCF − CapEx | $-20.77M | $-33.44M | $-17.95M | Not available |
Shares Outstanding | 9.07M | 3.65M | 840.25K | 20.93M |